The PE Ratio as of November 2024 (TTM) for POINT Biopharma Global Inc. (PNT) is 11.36

According to POINT Biopharma Global Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 11.36. This represents a change of -267.81% compared to the average of -6.77 of the last 4 quarters.

POINT Biopharma Global Inc. (PNT) Historical PE Ratio (quarterly & annually)

How has PNT PE Ratio performed in the past?

The mean historical PE Ratio of POINT Biopharma Global Inc. over the last ten years is -10.59. The current 11.36 PE Ratio has changed -10832.33% with respect to the historical average. Over the past ten years (40 quarters), PNT's PE Ratio was at its highest in in the December 2022 quarter at 1.07. The PE Ratio was at its lowest in in the June 2020 quarter at -84.84.

POINT Biopharma Global Inc. (PNT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of POINT Biopharma Global Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

POINT Biopharma Global Inc. (PNT) Average PE Ratio

How has PNT PE Ratio performed in the past?

The current PE Ratio of POINT Biopharma Global Inc. (PNT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

POINT Biopharma Global Inc. (PNT) PE Ratio vs. Peers

How is PNT’s PE Ratio compared to its peers?

POINT Biopharma Global Inc.’s PE Ratio is greater than ORIC Pharmaceuticals, Inc. (-6.02), greater than Lyra Therapeutics, Inc. (-0.17), greater than Inhibrx Biosciences, Inc. (0.14), greater than ESSA Pharma Inc. (-2.61), greater than Crinetics Pharmaceuticals, Inc. (-17.36), greater than ALX Oncology Holdings Inc. (-0.45), greater than Immatics N.V. (-11.99), greater than BioAtla, Inc. (-0.92), greater than Aerovate Therapeutics, Inc. (-0.89), greater than Cerevel Therapeutics Holdings, Inc. (-17.73), greater than RAPT Therapeutics, Inc. (-0.73), greater than Cyteir Therapeutics, Inc. (-3.52), greater than Pardes Biosciences, Inc. (-1.36), greater than Third Harmonic Bio, Inc. (-27.19), greater than PMV Pharmaceuticals, Inc. (-1.73), greater than Edgewise Therapeutics, Inc. (-27.83), greater than Enochian Biosciences, Inc. (-1.36), greater than Revolution Medicines, Inc. (-17.77), greater than NewAmsterdam Pharma Company N.V. (-7.40), greater than Centessa Pharmaceuticals plc (-11.03), greater than Sutro Biopharma, Inc. (-2.41), greater than Opthea Limited (-1.53), greater than HilleVax, Inc. (-0.60),

Build a custom stock screener for POINT Biopharma Global Inc. (PNT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like POINT Biopharma Global Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

POINT Biopharma Global Inc. (PNT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like POINT Biopharma Global Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.